These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of human picornaviruses by nucleic acid probes. Hyypiä T Mol Cell Probes; 1989 Dec; 3(4):329-43. PubMed ID: 2559319 [TBL] [Abstract][Full Text] [Related]
3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
4. An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections. Jurgeit A; Moese S; Roulin P; Dorsch A; Lötzerich M; Lee WM; Greber UF Virol J; 2010 Oct; 7():264. PubMed ID: 20937137 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses. Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589 [TBL] [Abstract][Full Text] [Related]
6. Current status of anti-picornavirus therapies. Barnard DL Curr Pharm Des; 2006; 12(11):1379-90. PubMed ID: 16611122 [TBL] [Abstract][Full Text] [Related]
7. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
8. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants]. Koprowski H Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429 [TBL] [Abstract][Full Text] [Related]
9. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Norder H; De Palma AM; Selisko B; Costenaro L; Papageorgiou N; Arnan C; Coutard B; Lantez V; De Lamballerie X; Baronti C; Solà M; Tan J; Neyts J; Canard B; Coll M; Gorbalenya AE; Hilgenfeld R Antiviral Res; 2011 Mar; 89(3):204-18. PubMed ID: 21236302 [TBL] [Abstract][Full Text] [Related]
10. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections. Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620 [TBL] [Abstract][Full Text] [Related]
11. Molecular Basis of Coronavirus Virulence and Vaccine Development. Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626 [TBL] [Abstract][Full Text] [Related]
12. Vaccination against acute respiratory virus infections and measles in man. Osterhaus AD; de Vries P Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542 [TBL] [Abstract][Full Text] [Related]
13. Reverse Genetics Approaches for the Development of Influenza Vaccines. Nogales A; Martínez-Sobrido L Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025504 [TBL] [Abstract][Full Text] [Related]
14. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V; Kyriakopoulou Z; Markoulatos P Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246 [TBL] [Abstract][Full Text] [Related]